# Miltenyi Biotec

Source: https://onco.cc/companies/miltenyi-biotec/  
OnCo record `miltenyi-biotec` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Miltenyi Biotec, a private German company, makes the CliniMACS Prodigy, a closed automated device that manufactures CAR-T cells at the point of care, plus the magnetic cell separation and lentiviral vectors behind it, and its own CD20/CD19 bispecific CAR-T is in late-stage lymphoma trials.

## Summary

Private German company supplying magnetic cell separation (CliniMACS), closed automated manufacturing (Prodigy), lentiviral vectors, and its own CAR-T candidates (zamtocabtagene autoleucel, MB-CART2019.1, a CD20/CD19 bispecific CAR-T in late-stage trials for lymphoma). A backbone of point-of-care cell manufacturing in Europe and Asia.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Bergisch Gladbach
- Type: cell-therapy
- Website: https://www.miltenyibiotec.com

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Miltenyi_Biotec
- Official website: https://www.miltenyibiotec.com

## Connected records

- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/)
- technologies: [Autologous CAR-T manufacturing, batch by batch](https://onco.cc/technologies/car-t-manufacturing-process/), [Closed automated cell-therapy manufacturing](https://onco.cc/technologies/closed-automated-cell-manufacturing/), [Point-of-care and decentralised cell manufacturing](https://onco.cc/technologies/point-of-care-cell-manufacturing/)

---
JSON: https://onco.cc/api/v1/entities/miltenyi-biotec.json